ClinicalTrials.Veeva

Menu

Schizophrenia TreAtment With electRic Transcranial Stimulation (STARTS)

U

University of Sao Paulo

Status and phase

Completed
Phase 3

Conditions

Schizophrenia

Treatments

Device: Transcranial Direct Current Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT02535676
31063714.1.1001.0068

Details and patient eligibility

About

The aim of this study is to evaluate the therapeutic efficacy of tDCS (transcranial direct current stimulation) for treatment of negative symptoms in patients with schizophrenia. The proposed design is a clinical trial, randomized, double-blind, placebo-controlled study. Participants will receive ten sessions of active or sham stimulation in five consecutive days. 100 patients will be randomized into two groups (active tDCS vs sham tDCS) and will be assessed after the intervention: 2, 4, 6 and 12 weeks after. As objectives, the investigators expect to see a clinical improvement of negative symptoms through scales PANSS (Positive and Negative Syndrome Scale), Calgary, Auditory verbal hallucinations, SANS (Skills for Assessment of Negative Symptoms), and expect improvement on computerized cognitive tests. Another goal is to see improvement in biological markers related to schizophrenia, plasma and DNA will be stored.

Enrollment

100 patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of schizophrenia according to DSM-IV criteria and confirmed by the SCID
  • Minimum score of 20 points in the sum of negative PANSS
  • Stable antipsychotic medications

Exclusion criteria

  • Unstable medical illness
  • Uncontrolled pretreatment with rTMS or tDCS
  • At least six months without being in ECT
  • Benzodiazepines in doses of 10mg of diazepam
  • Electronic or metal implants in the cephalic segment.
  • Other mental disorders and dependence of substances

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 2 patient groups

Active tDCS
Active Comparator group
Description:
Sham Comparator: Sham Stimulation In active stimulation, the anode is placed over the left dorsolateral prefrontal cortex and the cathode is placed over the temporo-parietal cortex with the Transcranial Direct Current Stimulation. The device will deliver a charge of 2mA for 20 minutes.
Treatment:
Device: Transcranial Direct Current Stimulation
Sham tDCS
Sham Comparator group
Description:
Sham Comparator: Sham Stimulation In active stimulation, the anode is placed over the left dorsolateral prefrontal cortex and the cathode is placed over the temporo-parietal cortex with the Transcranial Direct Current Stimulation. The device will deliver a charge of 2mA for 1 minute, after that the device will be automatically turned off for 19 minutes.
Treatment:
Device: Transcranial Direct Current Stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems